Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Transl Androl Urol ; 10(5): 2019-2026, 2021 May.
Article in English | MEDLINE | ID: mdl-34159082

ABSTRACT

BACKGROUND: Human papillomavirus (HPV) infection is a risk factor for penile cancer (PC). The miR-145 expression has been correlated to this virus genomic amplification. In this context, this work aims to determine the expression level of miR-145 in penile tumors infected by high-risk HPV and correlate it with the clinicopathological characteristics of the tumor and protein expression of p53. METHODS: Formalin-fixed paraffin-embedded from 52 patients with PC, at diagnosis and prior to any cancer treatment, were obtained. HPV identification was performed by nested type PCR, and miR-145 expression was obtained by qRT-PCR. Immunohistochemical analysis of p53 and Ki-67 was performed. RESULTS: Tumoral miR-145 expression was significantly lower compared to adjacent tissue. Additionally, there was a significant reduction of miR-145 expression in invasion perineural, histological associated HPV, and absence of p53 expression in positive HPV cases. HPV infection was detected in 86.5%, the most frequent HPV16. Reduced disease-free survival was observed in patients with low expression of miR-145. CONCLUSIONS: Our data suggest that the underexpression of miR-145 may be triggered by HPV action, decreasing protein expression of p53, and being correlated with perineural invasion. Therefore, the deregulation of miR-145 provides clues as to the potential role in penile carcinogenesis and is also a potential candidate for validation in noninvasive samples.

2.
Asian Pac J Cancer Prev ; 21(2): 391-397, 2020 Feb 01.
Article in English | MEDLINE | ID: mdl-32102516

ABSTRACT

BACKGROUND: Inguinal lymph node involvement is the main prognostic factor in patients with penile cancer. However, there is a lack of marker/s for lymph node metastasis. microRNAs have been investigated as potential markers for prognosis of various types of cancer. Taking this into consideration, our main goal was to determine the association of miR-223-3p, miR-107, and miR-21-5p expression with clinicopathological characteristics, as well as presence of lymph node metastasis in patients with penile cancer. METHODS: Formalin-fixed paraffin-embedded penile squamous cell carcinoma specimens from 50 patients, at diagnosis and prior to any cancer treatment, were obtained. Tissue samples comprising at least 70% malignant cells and adjacent non-tumor tissues were evaluated by using qRT-PCR for expression level of miR-223-3p, miR-107 and miR-21-5p. Additionally, molecular identification of HPV was performed by PCR, and the expression levels of PTEN were analyzed by immunohistochemistry. RESULTS: Penile squamous cell carcinoma primary tumors presented higher expression of miR-223-3p, miR-107, and miR-21-5p when compared to non-tumor adjacent tissues. Upregulation of miR-223-3p was associated lymph node metastasis. Higher expression of miR-107 was associated with worsening of prognosis (as observed by histological grade II and III, tumors bigger than 2.0 cm, stage III and IV, and lower disease-free survival). In addition, higher expression of miR-107 and miR-21-5p was correlated to the absence of PTEN protein expression. CONCLUSIONS: Our data demonstrate that higher expression of miR-223-3p, miR-107, and miR-21-5p is correlated with poor prognosis in penile cancer. The upregulation of these microRNAs potentially affect critical cancer pathways and may be important for the prognosis and response to therapy in penile cancer.


Subject(s)
Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/pathology , Gene Expression Regulation, Neoplastic , MicroRNAs/genetics , Penile Neoplasms/pathology , Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/surgery , Follow-Up Studies , Gene Expression Profiling , Humans , Male , Middle Aged , PTEN Phosphohydrolase/metabolism , Penile Neoplasms/genetics , Penile Neoplasms/metabolism , Penile Neoplasms/surgery , Prognosis
3.
PLoS One ; 13(10): e0205350, 2018.
Article in English | MEDLINE | ID: mdl-30312320

ABSTRACT

BACKGROUND: Infection with human papillomavirus (HPV) is reported to be present in 30-50% of penile cancer cases. The immunohistochemical test for p16INK4a is used as an indicator of the presence of HPV and as a prognostic marker for squamous cell carcinomas in various sites. However, the role of this marker in penile carcinoma has not yet been completely elucidated. The aim of this study was to analyze whether the expression of p16INK4a is associated with the presence of HPV, histological parameters, and survival in penile cancer. METHODS: A study was conducted from 2014 to 2016 that included 55 patients with penile carcinoma. HPV DNA was detected through PCR using fresh tumor tissue, and immunohistochemistry was performed for analysis of p16INK4a protein using paraffin-embedded tissue. Evaluation of histological parameters was performed following complete embedding of the tumor tissue in paraffin. RESULTS: HPV DNA (low-risk and high-risk genotypes) was found in 49 (89.1%) cases, and 46/49 (93.9%) showed high-oncogenic risk HPV (HR-HPV). Of the 22 cases positive for p16INK4a, HR-HPV DNA was present in 21 (95.5%) (p = 0.032). Regarding histological parameters, p16INK4a and HR-HPV were significantly associated only with tumor subtype (p = 0.036 and p = 0.032, respectively); all carcinomas with basaloid characteristics were positive for p16INK4a. Although HPV+ patients had a higher disease-free survival (p <0.001), p16INK4a expression was not associated with patient survival. CONCLUSIONS: Our study, using fresh tissue samples, showed the highest incidence of HPV compared to that observed in the literature. Expression of the p16INK4a protein was significantly associated with the presence of HR-HPV and this expression may serve as a marker for the presence of the virus. The p16INK4a protein was not associated with the histological prognostic parameters, with the exception of tumor subtype, nor with patient survival. In the results, we showed that the objective of the present study was reached.


Subject(s)
Biomarkers, Tumor/genetics , Cyclin-Dependent Kinase Inhibitor p16/genetics , Papillomavirus Infections/genetics , Penile Neoplasms/genetics , Aged , Carcinogenesis/genetics , Gene Expression Regulation, Neoplastic , Genotype , Human papillomavirus 6/pathogenicity , Humans , Male , Middle Aged , Papillomavirus Infections/complications , Papillomavirus Infections/pathology , Papillomavirus Infections/virology , Penile Neoplasms/complications , Penile Neoplasms/pathology , Penile Neoplasms/virology
4.
BMC Urol ; 18(1): 50, 2018 May 29.
Article in English | MEDLINE | ID: mdl-29843769

ABSTRACT

BACKGROUND: The objectives of this study were to determine the minimum incidence of penile cancer in the poorest Brazilian state, and to describe the epidemiologic and clinical characteristics of patients diagnosed with the disease. METHODS: A retrospective study of 392 patients diagnosed with penile cancer in the three most important referral center in the state was conducted during 2004-2014. RESULTS: The age-standardized incidence was 6.15 per 100,000 and the crude annual incidence was 1.18 per 100,000. More than half (61.1%) of the tumors were histological grades 2 and 3, and 66.4% of tumors were classified as at least stage T2. The average age of patients was 58.6 ± 15.7 years (range, 18 to 103 years), with 20.8% of patients ≤40 years of age at diagnosis. The vast majority underwent penectomy (93%). Only 41.8% underwent lymphadenectomy, 58 patients (14.8%) received chemotherapy, and 54 patients (13.8%) received radiotherapy. Stage 3/4 and vascular invasion were statically significant at disease-free survival analysis. CONCLUSION: The state of Maranhão has the highest incidence of penile cancer in Brazil and globally. Tumors are locally advanced and at the time of diagnosis, and there is a high frequency among young individuals. Patients have a low socioeconomic status, making it difficult to complete treatment and receive appropriate follow-up.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/epidemiology , Global Health , Penile Neoplasms/diagnosis , Penile Neoplasms/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Brazil/epidemiology , Carcinoma, Squamous Cell/surgery , Disease-Free Survival , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Penile Neoplasms/surgery , Retrospective Studies , Young Adult
5.
Rev. bras. cir ; 87(6): 245-8, nov.-dez. 1997. tab
Article in Portuguese | LILACS | ID: lil-280201

ABSTRACT

Durante o período de julho de 1993 a junho de 1996, 143 pacientes foram admitidos no Hospital Municipal Djalma Marques, em Säo Luís-MA com traumatismo do intestino gross. Havia 129 pacientes do sexo masculino(90.2 por cento) e a média de idade foi de 28,7 anos. O cólon transverso foi lesado em 61 pacientes (42,7 por cento). O reparo primário, incluindo a sutura primária e ressecçäo com anastomose, foi realizado em 77 pacientes (53,8 por cento), colostomia em 52 pacientes (36,4 por cento) e a esxteriorizaçäo em 13 pacientes (9,1 por cento). A principal complicaçäo foi a infecçäo da ferida operatória em 12 pacientes (8,4 por cento). Os autores concluem que o reparo primário das lesöes do intestino grosso pode ser realizado com índices de complicaçöes inferiores à colostomia.


Subject(s)
Humans , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Abdominal Injuries/classification , Colon/injuries , Colon/surgery , Colostomy , Intestine, Large/injuries , Intestine, Large/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...